Improvisatory Music for Anxiety in Alzheimer's Disease

Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music

Recruiting N/A Interventional Study
Alzheimer's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Northwestern University · Other
Who this trial is looking for

This trial is looking for people with Alzheimer's disease and anxiety, along with their caregivers. Participants will take part in music sessions designed to help reduce anxiety or listen to calming stories over four weeks.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with Alzheimer's disease.
  • I have positive Alzheimer's disease biomarkers.
  • I have a Mini-Mental State Exam score of 15 or higher.
  • I have a RAID score above 8.

You may not be able to join if

  • I have significant hearing impairments.
  • I have major comorbidities with a Beck Depression Inventory score above 10.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study examines whether Clinically Designed Improvisatory Music (CDIM) can reduce anxiety in people living with Alzheimer's disease and anxiety (AD-A), and whether it can also lessen caregiver burden. CDIM is a live, receptive music-based intervention that uses slow tempi, simple diatonic melodic lines, soft dynamics, and periodic pauses to promote relaxation. As described in the proposal, CDI…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Clinical diagnosis of Alzheimer's Disease * Positive Alzheimer's disease biomarkers (blood test, amyloid PET scan or CSF) * Mini-mental State Exam (MMSE) \>=15 * Rating for Anxiety in Dementia (RAID) score \> 8 Exclusion Criteria * Significant hearing impairments * Major como…
Contacts

Borna Bonakdarpour - Associate Professor, MD, FAAN, FANA

(312) 503-5170

bbk@northwestern.edu

CONTACT